heidi-besen
Heidi Besen / Shutterstock.com
5 June 2020Big PharmaRory O'Neill

Has the public got the taste for free medicine?

The COVID-19 pandemic has seen the fundamental principles of the IP system, normally a touchstone of advanced economies, called into question. Governments and manufacturers alike are under pressure to assure the public that IP will not be a barrier to accessing the tools needed to fight the disease.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Africa
29 May 2020   The World Health Organization has launched a COVID-19 technology pool, with 37 countries and multiple international partners and institutions rallying together to support the initiative.
Americas
4 June 2020   The leaders of some of the world’s largest pharma companies appear to be resistant to a World Health Organization voluntary pool aimed at making vaccines, tests, treatments and other health technologies to fight COVID-19 accessible to all.
Americas
9 June 2020   Concerns that IP is hindering the development of tools to fight the COVID-19 are unfounded, and now is the time that we need IP the most, according to big pharma representatives.

More on this story

Africa
29 May 2020   The World Health Organization has launched a COVID-19 technology pool, with 37 countries and multiple international partners and institutions rallying together to support the initiative.
Americas
4 June 2020   The leaders of some of the world’s largest pharma companies appear to be resistant to a World Health Organization voluntary pool aimed at making vaccines, tests, treatments and other health technologies to fight COVID-19 accessible to all.
Americas
9 June 2020   Concerns that IP is hindering the development of tools to fight the COVID-19 are unfounded, and now is the time that we need IP the most, according to big pharma representatives.

More on this story

Africa
29 May 2020   The World Health Organization has launched a COVID-19 technology pool, with 37 countries and multiple international partners and institutions rallying together to support the initiative.
Americas
4 June 2020   The leaders of some of the world’s largest pharma companies appear to be resistant to a World Health Organization voluntary pool aimed at making vaccines, tests, treatments and other health technologies to fight COVID-19 accessible to all.
Americas
9 June 2020   Concerns that IP is hindering the development of tools to fight the COVID-19 are unfounded, and now is the time that we need IP the most, according to big pharma representatives.